Publication Name	World Journal of Hepatology
Manuscript ID	113753
Country	United States

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Cohort Study
Article Title	Impact of multidisciplinary steatotic liver disease management on bariatric surgery referral and clinical outcomes: A retrospective cohort study
Manuscript Source	Invited Manuscript
All Author List	Andrew W Schwartz, Emily Y Park, Ysabel C Ilagan-Ying, Zoe E Zimmerman, Bryan Bollinger, Lee D Ying, Yanhong D Deng, Andrew J Duffy, John M Morton, Wajahat Z Mehal, Albert Do and Bubu A Banini
Funding Agency and Grant Number	Funding Agency Grant Number National Institute of Diabetes and Digestive and Kidney Diseases 5R01DK134624-02, 5P30DK034989-40 8073
Corresponding Author	Bubu A Banini, Assistant Professor, Section of Digestive Diseases, Department of Internal Medicine, Yale School of Medicine, 40 Temple St, Suite 1A, New Haven, CT 06510, United States. bubu.banini@yale.edu
Key Words	Bariatric surgery; Metabolic dysfunction-associated steatotic liver disease; Metabolic dysfunction-associated steatohepatitis; Fatty liver disease; Obesity medicine; Weight loss; Multidisciplinary care; Transient elastography
Core Tip	Bariatric surgery should be considered as a therapeutic option in eligible patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Integration of weight management into a tertiary care center’s MASLD-specific clinic led to substantial improvement in referral rates for bariatric surgery when compared with the national average, with improved weight loss and liver-related outcomes one-year post surgery. Multidisciplinary obesity medicine and hepatology co-management is an effective model for MASLD care and promotes access to bariatric surgery.
Citation	Schwartz AW, Park EY, Ilagan-Ying YC, Zimmerman ZE, Bollinger B, Ying LD, Deng YD, Duffy AJ, Morton JM, Mehal WZ, Do A, Banini BA. Impact of multidisciplinary steatotic liver disease management on bariatric surgery referral and clinical outcomes: A retrospective cohort study. World J Hepatol 2025; In press

Received	2025-09-02 05:55
Peer-Review Started	2025-09-02 05:55
First Decision by Editorial Office Director	2025-09-04 07:46
Return for Revision	2025-09-04 07:46
Revised	2025-09-18 03:33
Publication Fee Transferred
Second Decision by Editor	2025-12-01 03:10
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2025-12-01 11:40
Articles in Press	2025-12-01 11:40
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com